First Tracks Biotherapeutics stock surges 20% on celiac trial data

Kraig Biocraft files for expanded investment license for subsidiary

Investing.com · News 9m ago

InvestingPro Fair Value nails 67% return on Everforth stock

Investing.com · News 11m ago

Robinhood has underperformed this year. Evercore ISI says the stock is a buy

CNBC · Economy 11m ago

Bristol Myers Squibb stock surges on dual phase 3 clinical trial successes

Investing.com · News 15m ago

Bristol Myers Squibb stock surges on dual phase 3 clinical trial successes

Investing.com · Investing_news 15m ago

Cuba denies involvement with island-bound fuel shipments seized by US

Investing.com · News 15m ago

5 ETFs I'm Buying and Holding Through the Next Bear Market and Beyond

NASDAQ · Markets 17m ago

AxoGen stock initiated at Buy by BofA on growth outlook

Investing.com · News 17m ago

BofA raises Helmerich & Payne stock price target to $46 on tech edge

Investing.com · News 17m ago

BofA cuts Insmed stock price target on valuation concerns

Investing.com · News 17m ago